蛛网膜下腔出血后继发性脑血管痉挛的研究进展

刘思齐 张艳 孙娟* 陈春花*

doi:10.16098/j.issn.0529-1356.2019.04.023

PDF(968 KB)

解剖学报 ›› 2019, Vol. 50 ›› Issue (4) : 537-542. DOI: 10.16098/j.issn.0529-1356.2019.04.023

综述

蛛网膜下腔出血后继发性脑血管痉挛的研究进展

刘思齐¹张艳²孙娟^3* 陈春花^2*

作者信息 +

Progress of mechanism and therapy on cerebral vasospasm after subarachnoid hemorrhage

LIU Si-qi¹ZHANG Yan² SUN Juan^3* CHEN Chun-hua ^2*

Author information +

文章历史 +

摘要

蛛网膜下腔出血（SAH）约占所有脑卒中患者的5%，具有极高的致残率和致死率。SAH后继发性脑血管痉挛（CVS）导致流向大脑重要部位的血液中断，进而引起脑缺血，是导致SAH后高致残率和死亡率的主要并发症之一，通常发生在SAH之后的3～12 d，平均持续两周。SAH后CVS的发生机制十分复杂，是多因素、多环节共同参与的过程，主要包括溶血产物产生，血管舒张收缩因子失衡，炎症、信号级联反应的激活及细胞凋亡及相关基因的表达。SAH后CVS的治疗分为介入治疗和药物治疗。有效地预测、预防和治疗CVS将显著提高SAH后患者的生存率及生活质量。我们就SAH后脑血管痉挛的发生机制及治疗措施的研究进展进行简要综述。

Abstract

Subarachnoid hemorrhage (SAH) accounts for about 5% of all stroke patients, with high disability and mortality. Secondary cerebral vasospasm (CVS) after SAH interrupts cerebral blood flow to important parts of the brain, and then causes cerebral ischemia, which is one of the major complications of the disability and mortality. CVS usually occurring 3 to 12 days after SAH and lasted for an average of two weeks. The mechanism of CVS after SAH is very complex, and it is a process involving multiple factors and links, including hemolysis products, imbalance of vasodilator and vasoconstrictors, inflammation, activation of signal cascade reaction, apoptosis and expression of related genes. The treatment of CVS after SAH is divided into interventional therapy and drug therapy. Effective prediction, prevention, and treatment of CVS will significantly improve survival and quality of life after SAH. This article briefly reviews progress of the research on the mechanism and treatment of cerebral vasospasm af er SAH.

导出引用

刘思齐张艳孙娟陈春花. 蛛网膜下腔出血后继发性脑血管痉挛的研究进展[J]. 解剖学报. 2019, 50(4): 537-542 https://doi.org/10.16098/j.issn.0529-1356.2019.04.023

LIU Si-qi ZHANG Yan SUN Juan CHEN Chun-hua. Progress of mechanism and therapy on cerebral vasospasm after subarachnoid hemorrhage[J]. Acta Anatomica Sinica. 2019, 50(4): 537-542 https://doi.org/10.16098/j.issn.0529-1356.2019.04.023

参考文献

［1］ Sun J, Zhang Y, Xu T, te al. Rhynchophylline attenuates cerebral vasospasm after subarachnoid hemorrhage in rats ［J］. Acta Anatomica Sinica，2014, 45(6):749-754. (in Chinese)

孙娟, 张艳, 徐霆, 等. 钩藤碱减轻大鼠蛛网膜下腔出血后脑血管痉挛［J］. 解剖学报, 2014, 45(6): 749-754.

［2］ Przybycien-Szymanska MM, Ashley WW Jr. Biomarker discovery in cerebral vasospasm after aneurysmal subarachnoid hemorrhage ［J］. J Stroke Cerebrovasc Dis, 2015, 24(7): 1453-1464.

［3］ Vatter H, Weidauer S, Dias S, et al. Persistence of the nitric oxide-dependent vasodilator pathway of cerebral vessels after experimental subarachnoid hemorrhage ［J］. Neurosurgery, 2007, 60(1): 179-188.

［4］ Osuka K, Watanabe Y, Usuda N, et al. Modification of endothelial nitric oxide synthase through AMPK after experimental subarachnoid hemorrhage ［J］. J Neurotrauma, 2009, 26(7): 1157-1165.

［5］ Shih HC, Lin CL, Wu SC, et al. Upregulation of estrogen receptor alpha and mediation of 17beta-estradiol vasoprotective effects via estrogen receptor alpha in basilar arteries in rats after experimental subarachnoid hemorrhage ［J］. J Neurosurg, 2008, 109(1): 92-99.

［6］ Vatter H, Konczalla J, Weidauer S, et al. Characterization of the endothelin-B receptor expression and vasomotor function during experimental cerebral vasospasm ［J］. Neurosurgery, 2007, 60(6): 1100-1109.

［7］ Ansar S, Vikman P, Nielsen M, et al. Cerebrovascular ETB, 5-HT1B, and AT1 receptor upregulation correlates with reduction in regional CBF after subarachnoid hemorrhage ［J］. Am J Physiol Heart Circ Physiol, 2007, 293(6): H3750-3758.

［8］ Sugden PH, Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors ［J］. Cell Signal, 1997, 9(5): 337-351.

［9］ Hishikawa T, Ono S, Ogawa T, et al. Effects of deferoxamine-activated hypoxia-inducible factor-1 on the brainstem after subarachnoid hemorrhage in rats ［J］. Neurosurgery, 2008, 62(1): 232-241.

［10］Yan J, Chen C, Lei J, et al. 2-methoxyestradiol reduces cerebral vasospasm after 48 hours of experimental subarachnoid hemorrhage in rats ［J］. Exp Neurol, 2006, 202(2): 348-356.

［11］McGirt MJ, Pradilla G, Legnani FG, et al. Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm ［J］. Neurosurgery, 2006, 58(5): 945-951.

［12］Wilkins RH. Cerebral vasospasm ［J］. Crit Rev Neurobiol, 1990, 6(1): 51-77.

［13］Iseda K, Ono S, Onoda K, et al. Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage ［J］. J Neurosurg, 2007, 107(1): 128-135.

［14］Lu H, Shi JX, Chen HL, et al. Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage ［J］. Brain Res, 2009,（1262）: 73-80.

［15］Karaoglan A, Akdemir O, Barut S, et al. The effects of resveratrol on vasospasm after experimental subarachnoidal hemorrhage in rats ［J］. Surg Neurol， 2008, 70(4): 337-343.［16］Endo H, Nito C, Kamada H, et al. Reduction in oxidative stress by superoxide dismutase overexpression attenuates acute brain injury after subarachnoid hemorrhage via activation of Akt/glycogen synthase kinase-3 beta survival signaling ［J］. J Cereb Blood Flow Metab， 2007, 27(5): 975-982.

［17］Sen O, Caner H, Aydin MV, et al. The effect of mexiletine on the level of lipid peroxidation and apoptosis of endothelium following experimental subarachnoid hemorrhage ［J］. Neurol Res，2006, 28(8): 859-863.

［18］Zhou C, Yamaguchi M, Kusaka G, et al. Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage ［J］. J Cereb Blood Flow Metab， 2004, 24(4): 419-431.

［19］Chen G, Zhang S, Shi J, et al. Effects of recombinant human erythropoietin (rhEPO) on JAK2/STAT3 pathway and endothelial apoptosis in the rabbit basilar artery after subarachnoid hemorrhage ［J］. Cytokine， 2009, 45(3): 162-168.

［20］Chen G, Wu J, Sun C, et al. Potential role of JAK2 in cerebral vasospasm after experimental subarachnoid hemorrhage ［J］. Brain Res，2008,（1214）: 136-144.

［21］Cahill J, Calvert JW, Solaroglu Ⅰ, et al. Vasospasm and p53-induced apoptosis in an experimental model of subarachnoid hemorrhage ［J］. Stroke， 2006, 37(7): 1868-1874.

［22］Sugawara T, Ayer R, Jadhav Ⅴ, et al. Simvastatin attenuation of cerebral vasospasm after subarachnoid hemorrhage in rats via increased phosphorylation of Akt and endothelial nitric oxide synthase ［J］. J Neurosci Res， 2008, 86(16): 3635-3643.

［23］Cheng G, Wei L, Zhi-Dan S, et al. Atorvastatin ameliorates cerebral vasospasm and early brain injury after subarachnoid hemorrhage and inhibits caspase-dependent apoptosis pathway ［J］. BMC Neurosci, 2009,10: 7.

［24］Tsurutani H, Ohkuma H, Suzuki S. Effects of thrombin inhibitor on thrombin-related signal transduction and cerebral vasospasm in the rabbit subarachnoid hemorrhage model ［J］. Stroke, 2003, 34(6): 1497-1500.

［25］Liu JK, Tenner MS, Oestreich HM, et al. Reversal of radiographically impending stroke with multiple intraarterial papaverine infusions in severe diffuse cerebral vasospasm induced by subarachnoid hemorrhage ［J］. Acta Neurochir (Wien)， 2001, 143(12): 1249-1256.

［26］Shankar JJ, dos Santos MP, Deus-Silva L, et al. Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage ［J］. Neuroradiology， 2011, 53(2): 123-128.

［27］Amin-Hanjani S, Ogilvy CS, Barker FG 2nd. Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis ［J］. Neurosurgery， 2004, 54(2): 326-334.

［28］Kim JH, Yi HJ, Ko Y, et al. Effectiveness of papaverine cisternal irrigation for cerebral vasospasm after aneurysmal subarachnoid hemorrhage and measurement of biomarkers ［J］. Neurol Sci， 2014, 35(5): 715-722.

［29］Gabikian P, Clatterbuck RE, Eberhart CG, et al. Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats ［J］. Stroke， 2002, 33(11): 2681-2686.

［30］Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution ［J］. Nat Clin Pract Neurol， 2007, 3(5): 256-263.

［31］Chyatte D. Prevention of chronic cerebral vasospasm in dogs with ibuprofen and high-dose methylprednisolone ［J］. Stroke， 1989, 20(8): 1021-1026.

［32］Chyatte D, Fode NC, Nichols DA, et al. Preliminary report: effects of high dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage ［J］. Neurosurgery， 1987, 21(2): 157-160.

［33］Ryba M, Pastuszko M, Dziewiecki C, et al. A strategy for analyzing multiple parameters with application to aneurysmal SAH patients all of them clipped but treated with and without cyclosporine ［J］. Acta Neurochir (Wien)， 1993, 122(34): 194-199.

［34］McGirt MJ, Lynch JR, Parra A, et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage ［J］. Stroke， 2002, 33(12): 2950-2956.

［35］Tseng MY, Czosnyka M, Richards H, et al. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase Ⅱ randomized placebo-controlled trial ［J］. Stroke，2005, 36(8): 1627-1632.

［36］Vergouwen MD, Algra A, Rinkel GJ. Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update ［J］. Stroke， 2012, 43(10): 2671-2676.

［37］Yamaguchi-Okada M, Nishizawa S, Mizutani A, et al. Multifaceted effects of selective inhibitor of phosphodiesterase Ⅲ, cilostazol, for cerebral vasospasm after subarachnoid hemorrhage in a dog model ［J］. Cerebrovasc Dis， 2009, 28(2): 135-142.

［38］Sun J, Zhang Y, Lu J, et al. Salvinorin a ameliorates cerebral vasospasm through activation of endothelial nitric oxide synthase in a rat model of subarachnoid hemorrhage ［J］. Microcirculation， 2018，25(3):e12442.